Essenvia unveils its 2024 State of US MedTech Regulation Industry Report that highlights shifts in innovation, AI & digital transformation in MedTech operations, and regulation in the United States medical device industry and provides MedTech executives and regulatory leaders with strategic insights, guidance, and best practices to navigate the shifting landscape in 2024 and beyond. 

The report covers topics including the rising role of artificial intelligence and digital transformation in MedTech regulation, explores the value-benefit and opportunity of Breakthrough Device Designation and TCET for novel devices, and unveils a vibrant and record-breaking innovation landscape in the United States post-COVID-19. With a focus on digital transformation, AI integration, and innovative device pathways, the report serves as an indispensable guide for navigating the evolving regulatory landscape, offering MedTech leaders strategic intelligence for future-proofing their operations.

YOU'LL LEARN : 

• Understand shifts in innovation, digital transformation, and AI in MedTech regulation

• Learn strategic insights on cost-benefit of various FDA pathways and programs

• Discover specific use cases for AI & Machine Learning in MedTech regulatory operations

• Executive guidance and best practices for navigating US regulation in 2024 and beyond

• Strategic guidance for investing in digital technologies to achieve regulatory excellence

WHO SHOULD ATTEND:

• MedTech CxO’s

• Regulatory Leaders

•  R&D Leaders

• Product & Strategy Leaders